Hospital News and Research

RSS

Hospital staff go on 4 hour strike over pay issues

Hospital staff across Western Australia will strike today for better pay. The Industrial Relations Commission failed to assure the government that it would stop workers from carrying out industrial action. On Friday, the union rejected an offer to increase their weekly pay by $27.

11 Oct 2010

Incentivized structured weight loss program with free prepared meals effectively promotes weight loss

In another article being released early online, Cheryl L. Rock, Ph.D., R.D., from Moores UCSD Cancer Center, La Jolla, Calif., and colleagues, conducted a randomized controlled trial of weight loss and weight maintenance in 442 overweight or obese women (BMI, 25 - 40), ages 18 to 69, over a two year period with follow-up between November 2007 and April 2010.

11 Oct 2010

New technologies and surgical techniques promise 'personalized' orthopedic operations

A number of new technologies and surgical techniques promise to "personalize" orthopedic operations such as hip and knee replacement, according to research to be presented at an educational program at Hospital for Special Surgery on October 15 and 16. During "Computer Assisted Orthopaedic Surgery: Review of Emerging Technologies," prominent orthopedic researchers will discuss how innovative technologies can improve surgical outcomes.

11 Oct 2010

Merck Serono announces first results from Erbitux BALI-1 study in metastatic triple-negative breast cancer

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced the first results from the BALI-1 study of Erbitux® (cetuximab) in the treatment of metastatic triple-negative breast cancer (TNBC), an aggressive cancer in which early relapse and metastasis are common. The data, presented during the 35th Congress of the European Society for Medical Oncology (ESMO), demonstrate that Erbitux has the potential to improve outcomes for women with this relentlessly devastating cancer.

11 Oct 2010

Chongqing Cancer Hospital commences treatment with Varian's RapidArc radiotherapy

Chongqing Cancer Hospital in Southwest China has become the first treatment center in Southwest China to offer cancer patients a faster, more precise form of image-guided radiotherapy that potentially enables doctors to improve outcomes while extending more advanced care to more patients. Clinicians at the hospital have used RapidArc® radiotherapy from Varian Medical Systems to treat patients for cancers of the nasopharynx, cervix, breast, and lung.

11 Oct 2010

CTCA in Tulsa purchases BSD-2000 Hyperthermia System

BSD Medical Corporation announced today that the Cancer Treatment Centers of America (CTCA), located in Tulsa, Oklahoma, has purchased a BSD-2000 Hyperthermia System (BSD-2000). CTCA in Tulsa is a state-of-the-art hospital that is totally focused on treating cancer patients and provides the most advanced therapeutic resources in cancer treatment.

11 Oct 2010

Health Robotics enters distribution agreements with Newico and Apta Medica for 7 new European countries

Health Robotics today announced that it recently signed exclusive distribution agreements for its CytoCare, i.v.STATION, and i.v.SOFT world-leading technologies in seven new European countries with regional industry leaders Newico and Apta Medica, rapidly continuing on its worldwide quest to pervasively provide safe and cost-effective Intravenous (IV) Admixture Compounding Automation to hospitals all over the world.

11 Oct 2010

New data on implementation of minimally invasive treatments for ruptured intracranial aneurysms

Two recent studies from the Zeenat Qureshi Stroke Research Center, in Minneapolis, MN, provide new data regarding implementation of minimally invasive treatments for ruptured intracranial aneurysms and impact on patient outcomes in U.S.

11 Oct 2010

Zotec enters 3-year billing services contract with West Coast Radiology Centers

Zotec Partners, an industry leader in medical billing, practice management and Radiology Information Systems (RIS) software and services, announces today that West Coast Radiology Centers (WCRC), out of Santa Ana/Tustin, Calif., has inked a three-year billing services contract with the company. WCRC operates nine imaging centers throughout Orange County.

11 Oct 2010

Florida Governor issues Proclamation recognizing outstanding work of Healthcare Quality Professionals

Florida Governor Charlie Crist issued a Proclamation recognizing the outstanding work Healthcare Quality Professionals do for the people of Florida. This proclamation mirrors the sentiments of National Healthcare Quality Week, October 17-23rd, which celebrates the work of Healthcare Quality Professionals in improving patient outcomes and healthcare delivery systems.

11 Oct 2010

AVEO presents tivozanib Phase 2 study results at ESMO Congress

AVEO Pharmaceuticals, Inc. a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that previously reported results from its Phase 2 study evaluating tivozanib for the treatment of advanced renal cell carcinoma (RCC) were presented at the 35th European Society for Medical Oncology (ESMO) Congress in Milan, Italy.

11 Oct 2010

Geron commences GRNOPC1 hESC-based cell therapy in patients with spinal cord injury

Geron Corporation today announced the enrollment of the first patient in the company's clinical trial of human embryonic stem cell (hESC)-derived oligodendrocyte progenitor cells, GRNOPC1. The primary objective of this Phase I study is to assess the safety and tolerability of GRNOPC1 in patients with "complete" American Spinal Injury Association (ASIA) Impairment Scale grade A thoracic spinal cord injuries. Participants in the study must be newly injured and receive GRNOPC1 within 14 days of the injury.

11 Oct 2010

ACT Biotech reports positive interim data from Telatinib Phase 2 trial for advanced gastric cancer

ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.

11 Oct 2010

NBM 200 system accurately measures hemoglobin level

OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, presented today at the AABB Annual Meeting & CTTXPO 2010, in Baltimore, Maryland, results showing that hemoglobin (Hb) measurements obtained by its NBM 200, a non-invasive Hb measurement system for anemia screening, showed accurate performance compared with invasive point of care (POC) devices.

11 Oct 2010

MOH approves BrainStorm's NurOwn stem cell therapy for Phase I/II clinical trial

BrainStorm Cell Therapeutics Inc. a leading developer of adult stem cell technologies and therapeutics, today announced that the Israeli Ministry of Health (MOH) has granted clearance for a Phase I/II clinical trial using the company's autologous NurOwn stem cell therapy in patients with amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's Disease.

11 Oct 2010

BioSante presents update on LibiGel clinical study at NAMS Annual Meeting

BioSante Pharmaceuticals, Inc. presented a LibiGel clinical study update at the 21st Annual Meeting of The North American Menopause Society (NAMS) on October 8, 2010, with more than 1,000 experts and practitioners in menopause and women's health in attendance.

11 Oct 2010

First Edition: October 11, 2010

Today's early morning highlights include articles on new options for open season, concerns among retirees about the provisions of the federal health law and the latest campaign arguments over that new overhaul.

11 Oct 2010

TTF therapy with chemotherapy increases survival time in patients with non-small cell lung cancer

Novocure reported today that patients with advanced non-small cell lung cancer (NSCLC) achieved a significant increase in survival time when tumor treating fields (TTF) therapy was added to chemotherapy, as compared to previously reported outcomes for patients receiving chemotherapy alone.

11 Oct 2010

CCHIT certifies Health Care Systems' eMR Version 4

Health Care Systems, Inc. (HCS) announced today that HCS eMR, Version 4, is 2011/2012 compliant and was certified as an EHR Module on 9/30/2010 by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable HOSPITAL certification criteria adopted by the Secretary of Health and Human Services. The 2011/2012 criteria support the Stage 1 meaningful use measures required to qualify eligible providers and hospitals for funding under the American Recovery and Reinvestment Act (ARRA).

11 Oct 2010

Study to uncover genetic basis of obesity

An international consortium has made significant inroads into uncovering the genetic basis of obesity by identifying 18 new gene sites associated with overall obesity and 13 that affect fat distribution. The studies include data from nearly a quarter of a million participants, the largest genetic investigation of human traits to date.

11 Oct 2010

Hospital News and Research

Hospital staff go on 4 hour strike over pay issues

Incentivized structured weight loss program with free prepared meals effectively promotes weight loss

New technologies and surgical techniques promise 'personalized' orthopedic operations

Merck Serono announces first results from Erbitux BALI-1 study in metastatic triple-negative breast cancer

Chongqing Cancer Hospital commences treatment with Varian's RapidArc radiotherapy

CTCA in Tulsa purchases BSD-2000 Hyperthermia System

Health Robotics enters distribution agreements with Newico and Apta Medica for 7 new European countries

New data on implementation of minimally invasive treatments for ruptured intracranial aneurysms

Zotec enters 3-year billing services contract with West Coast Radiology Centers

Florida Governor issues Proclamation recognizing outstanding work of Healthcare Quality Professionals

AVEO presents tivozanib Phase 2 study results at ESMO Congress

Geron commences GRNOPC1 hESC-based cell therapy in patients with spinal cord injury

ACT Biotech reports positive interim data from Telatinib Phase 2 trial for advanced gastric cancer

NBM 200 system accurately measures hemoglobin level

MOH approves BrainStorm's NurOwn stem cell therapy for Phase I/II clinical trial

BioSante presents update on LibiGel clinical study at NAMS Annual Meeting

First Edition: October 11, 2010

TTF therapy with chemotherapy increases survival time in patients with non-small cell lung cancer

CCHIT certifies Health Care Systems' eMR Version 4

Study to uncover genetic basis of obesity

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News